CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer — Stella

Home/Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Trial locations(1 site)

China

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai Municipality

Key details

Sponsor

RenJi Hospital

Enrollment target

~172 participants

Started

April 2023

Primary completion

April 2026

Age range

18 Years and older

Last updated May 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.